Monday, 31 August 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

ESTORIL SOL N Stock Is 9% Up So Far Today

Loading stream...

(VIANEWS) - Shares of ESTORIL SOL N (PSI: ESON.LS) jumped 9.77% to €7.30 at 13:24 EST on Thursday, after five sequential sessions in a row of losses. PSI is rising 0.83% to €5,978.80, after two sequential sessions in a row of losses. This seems, up to now, a somewhat bullish trend trading session today.

About ESTORIL SOL N

Estoril Sol, SGPS, S.A., together with its subsidiaries, engages in the gaming activities and real estate businesses. It owns gaming casinos, including casino do Estoril, Casino Lisboa, and Casino da Póvoa. The company is also involved in the online casino games and gambling business, as well as online sports betting activities. In addition, it owns a plot of land in Monte Estoril. Further, the company engages in tourism business. The company was incorporated in 1958 and is headquartered in Estoril, Portugal. Estoril Sol, SGPS, S.A. is a subsidiary of Finansol - Sociedade de Controlo, SGPS, S.A.

Earnings Per Share

As for profitability, ESTORIL SOL N has a trailing twelve months EPS of €-0.12.

More news about ESTORIL SOL N (ESON.LS).

Categories

stockMarket

Tags

Stock PriceMarket Session NowStock Market NowPrice UpMarket SessionStock Price UpESON.LSStock MarketStockESTORIL SOL N
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com